Lesson 4: Stem cells, mitosis and differentiation

Evaluate an iPS cell therapy for macular degeneration

SkillStem cells and potency

Worked example

  • Complex unfamiliar
  • Technology free

In age-related macular degeneration, a layer of cells behind the retina (the retinal pigment epithelium) dies and central vision is lost. In 2014 researchers in Japan took skin cells from a patient, reprogrammed them into iPS cells, grew them into a sheet of retinal pigment epithelium and transplanted it into her eye. A year later the sheet was still in place, there was no sign of rejection or tumours, and her vision had stopped getting worse, though it had not improved.

Evaluate the use of iPS cells for this treatment, considering its safety, ethics and efficacy.

1 of 5 steps
  1. Step 1: Explain the biology

    iPS cells are specialised cells reprogrammed to be pluripotent, so they can be differentiated into the required cell type, here retinal pigment epithelium.

Try a similar one

A fresh question of the same kind, checked as you answer, with hints and a full solution.

Method

  1. Explain the relevant biology briefly (what iPS cells are).

  2. Give points for and against under safety, ethics and efficacy, each specific to the case.

  3. Comment on the strength of the evidence (sample size, follow-up time).

  4. Finish with a reasoned judgement.

Watch out for

  • Listing advantages and disadvantages without a final judgement.

  • Treating one successful case as proof that the treatment works.

Save your progress with a free account